Injections, Intraperitoneal
"Injections, Intraperitoneal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall.
Descriptor ID |
D007274
|
MeSH Number(s) |
E02.319.267.530.490
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Injections, Intraperitoneal".
Below are MeSH descriptors whose meaning is more specific than "Injections, Intraperitoneal".
This graph shows the total number of publications written about "Injections, Intraperitoneal" by people in this website by year, and whether "Injections, Intraperitoneal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2015 | 0 | 1 | 1 |
2017 | 0 | 7 | 7 |
2018 | 0 | 8 | 8 |
2019 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Injections, Intraperitoneal" by people in Profiles.
-
Reply to the Letter to the Editor "Pathogenesis of pneumoperitoneum in COVID-19 patients". Cir Esp (Engl Ed). 2021 Jun-Jul; 99(6):477-478.
-
Pathogenesis of pneumoperitoneum in a COVID-19 patients. Cir Esp (Engl Ed). 2021 Jun-Jul; 99(6):476-477.
-
Anti-inflammatory mechanisms of the novel cytokine interleukin-38 in allergic asthma. Cell Mol Immunol. 2020 06; 17(6):631-646.
-
Peritoneal Cells Mediate Immune Responses and Cross-Protection Against Influenza A Virus. Front Immunol. 2019; 10:1160.
-
The ameliorative effects of ceftriaxone and vitamin E against cisplatin-induced nephrotoxicity. Environ Sci Pollut Res Int. 2019 May; 26(15):15248-15254.
-
Isolinderalactone regulates the BCL-2/caspase-3/PARP pathway and suppresses tumor growth in a human glioblastoma multiforme xenograft mouse model. Cancer Lett. 2019 02 28; 443:25-33.
-
The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy. Antiviral Res. 2018 12; 160:38-47.
-
Intraperitoneal injection of nesfatin-1 primarily through the CCK-CCK1R signal pathway affects expression of appetite factors to inhibit the food intake of Siberian sturgeon (Acipenser baerii). Peptides. 2018 11; 109:14-22.
-
Inhibitor of IGF1 receptor alleviates the inflammation process in the diabetic kidney mouse model without activating SOCS2. Drug Des Devel Ther. 2018; 12:2887-2896.
-
Kasugamycin potentiates rifampicin and limits emergence of resistance in Mycobacterium tuberculosis by specifically decreasing mycobacterial mistranslation. Elife. 2018 08 28; 7.